The investigation of clinical effects of repaglinide in diabetic patients over 65 years old

Trial Profile

The investigation of clinical effects of repaglinide in diabetic patients over 65 years old

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Dec 2014

At a glance

  • Drugs Repaglinide (Primary)
  • Indications Diabetes mellitus
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 23 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top